STOCK TITAN

Quantum-Si Incorporated Stock Price, News & Analysis

QSI NASDAQ

Company Description

Company Overview

Quantum-Si Incorporated (QSI) is a specialized life sciences company dedicated to revolutionizing proteomics research with its cutting-edge approach to single-molecule detection and next-generation protein sequencing (NGPS). By leveraging a proprietary universal detection platform, the company delivers comprehensive solutions that integrate sophisticated hardware, purpose-designed consumables, and intuitive software tools. This holistic approach enables researchers to conduct protein analysis with unprecedented precision, addressing critical challenges in biomolecular discovery and diagnostics.

Innovative Platform and Technology

At the heart of Quantum-Si's business model is its innovative universal single-molecule detection platform. Designed to streamline the process of protein sequencing, the system is engineered to break down complex biological samples into quantifiable data, thereby accelerating the pace of discovery in proteomics. The integration of hardware, consumables, and software into a cohesive solution not only enhances data quality but also reduces operational complexities for high-commitment research teams. This technological synergy distinguishes Quantum-Si within the competitive landscape of biotechnology research instruments.

Operational Excellence and Environment

Quantum-Si has cultivated a unique work environment that encourages bright, committed individuals to innovate and solve challenging scientific problems. By empowering its team with the freedom to explore new scientific approaches and providing adequate resources, the company fosters a culture where creativity and rigorous scientific inquiry go hand in hand. This commitment to operational excellence is fundamental to developing products that effectively address the needs of researchers and professionals in the life sciences community.

Market Position and Competitive Landscape

Operating in the dynamic realm of proteomics, Quantum-Si holds an important niche in the biotech industry by addressing specific challenges related to protein detection and analysis. The company has strategically positioned itself against competitors by focusing on the deployment of its advanced, single-molecule detection technology, emphasizing its capacity for next-generation protein sequencing. Researchers and healthcare professionals seeking precise and efficient proteomic analysis find Quantum-Si's product offerings uniquely suited to drive scientific innovation and improved research outcomes.

Business Model and Revenue Generation

The company generates revenue through the commercialization of its proprietary detection platform, offering a blend of hardware, consumable products, and integrated software solutions. This approach not only creates multiple revenue streams but also anchors the company's position as a significant contributor to the proteomics research sector. Quantum-Si's business model is built upon delivering high-performance, reliable instruments to research institutions and laboratories globally, ensuring that the practical applications of its technology are both scalable and transformative.

Commitment to Quality and Expertise

Quantum-Si demonstrates a strong commitment to quality through a methodical approach to product development and validation. By embedding industry best practices into its research and development processes, the company ensures that every aspect of its technology—from hardware precision to software analytics—upholds a high standard of scientific reliability. This relentless pursuit of excellence underscores the firm’s dedication to advancing scientific discovery while maintaining robust operational frameworks.

Addressing Industry Needs with Advanced Proteomics Solutions

In a rapidly evolving scientific landscape, Quantum-Si continues to be driven by a mission to empower breakthroughs in health and discovery. Its universal detection platform addresses long-standing challenges in protein identification and sequencing, offering a unique solution that amalgamates technological innovation with practical application. The company is vocally committed to nurturing a culture of innovation and scientific rigor among its employees, ensuring that its technological advancements remain at the forefront of proteomics research.

In summary, Quantum-Si Incorporated stands out as a distinguished enterprise in the life sciences field due to its advanced proteomics research tools and its integrated approach to technology. The comprehensive suite of solutions provided by the company not only underlines its expertise in single-molecule detection and next-generation protein sequencing but also reinforces its relevance within the broader biotechnology ecosystem.

Stock Performance

$1.22
0.00%
0.00
Last updated: April 25, 2025 at 10:25
33 %
Performance 1 year
$212.4M
Market Cap
183.1M
Shares outstanding

SEC Filings

No SEC filings available for Quantum-Si Incorporated.

Financial Highlights

$787,000
Revenue (TTM)
-$25,313,000
Net Income (TTM)
-$0.18
Diluted EPS (TTM)
-$23,153,000
Operating Cash Flow
-3,216.39%
Net Profit Margin
-3,569.00%
Oper. Profit Margin

Upcoming Events

May 15, 2025
Q1 2025 earnings call
March 20, 2026
25% RSUs vest

Frequently Asked Questions

What is the current stock price of Quantum-Si Incorporated (QSI)?

The current stock price of Quantum-Si Incorporated (QSI) is $1.22 as of April 24, 2025.

What is the market cap of Quantum-Si Incorporated (QSI)?

The market cap of Quantum-Si Incorporated (QSI) is approximately 212.4M.

What is the revenue (TTM) of Quantum-Si Incorporated (QSI) stock?

The trailing twelve months (TTM) revenue of Quantum-Si Incorporated (QSI) is $787,000.

What is the net income of Quantum-Si Incorporated (QSI)?

The trailing twelve months (TTM) net income of Quantum-Si Incorporated (QSI) is -$25,313,000.

What is the earnings per share (EPS) of Quantum-Si Incorporated (QSI)?

The diluted earnings per share (EPS) of Quantum-Si Incorporated (QSI) is -$0.18 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Quantum-Si Incorporated (QSI)?

The operating cash flow of Quantum-Si Incorporated (QSI) is -$23,153,000.

What is the profit margin of Quantum-Si Incorporated (QSI)?

The net profit margin of Quantum-Si Incorporated (QSI) is -3,216.39%.

What is the operating margin of Quantum-Si Incorporated (QSI)?

The operating profit margin of Quantum-Si Incorporated (QSI) is -3,569.00%.

What is the gross margin of Quantum-Si Incorporated (QSI)?

The gross profit margin of Quantum-Si Incorporated (QSI) is 46.63%.

What is the current ratio of Quantum-Si Incorporated (QSI)?

The current ratio of Quantum-Si Incorporated (QSI) is 13.42, indicating the company's ability to pay short-term obligations.

What is the gross profit of Quantum-Si Incorporated (QSI)?

The gross profit of Quantum-Si Incorporated (QSI) is $367,000 on a trailing twelve months (TTM) basis.

What is the operating income of Quantum-Si Incorporated (QSI)?

The operating income of Quantum-Si Incorporated (QSI) is -$28,088,000.

What is the core focus of Quantum-Si Incorporated?

Quantum-Si is focused on developing advanced proteomics research tools. Its proprietary platform enables single-molecule detection and next-generation protein sequencing, offering comprehensive solutions for protein analysis.

How does Quantum-Si generate revenue?

The company generates revenue by commercializing an integrated solution that includes hardware, consumables, and software. This multi-faceted approach supports research institutions in executing precise proteomic analyses.

What distinguishes Quantum-Si’s technology from others in the market?

Quantum-Si’s universal single-molecule detection platform sets it apart by combining robust hardware with specialized consumables and analytics software. This integration facilitates higher accuracy in protein sequencing and detection.

Who are the primary users of Quantum-Si’s products?

The primary users include research institutions, laboratories, and professionals in the life sciences and biotechnology sectors. These users rely on Quantum-Si’s tools to advance scientific discovery and improve protein analysis methodologies.

In what ways does Quantum-Si foster innovation within its organization?

Quantum-Si empowers its employees by granting them ownership, resources, and the freedom to tackle complex scientific challenges. This unique culture drives innovation and supports the development of breakthrough proteomics solutions.

How does Quantum-Si position itself in the competitive biotech landscape?

By focusing on its unique single-molecule detection platform and next-generation protein sequencing capabilities, Quantum-Si differentiates itself from competitors. Its integrated approach to research tools caters to specific needs in the proteomics industry.

What benefits does Quantum-Si’s integrated solution offer to the research community?

The integrated solution streamlines the process of protein sequencing by reducing operational complexity and increasing data precision. This comprehensive approach enhances research efficiency and accelerates scientific discovery.